Updates from The Motley Fool

Latest updates on Alkermes, Inc. from Fool.com.

Stock Performance

ALKS vs. S&P 500 | 2 Year Performance
ALKS 1-Day Stock Chart
ALKS 5-Day Stock Chart
ALKS 1-Month Stock Chart
ALKS 3-Month Stock Chart
ALKS 6-Month Stock Chart
ALKS 1-Year Stock Chart
ALKS 2-Year Stock Chart
ALKS 5-Year Stock Chart
View Interactive ALKS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Alkermes, Inc..
Current Price: $43.58
Prev Close: $43.42
Open: $43.91
Bid: $41.88
Ask: $55.00
Day's Range: $43.03 - $44.37
52wk Range: $27.14 - $80.71
Volume: 913,027
Avg Vol 1,194,249
Market Cap: $6.54B
P/E (ttm): -23.86
EPS (ttm): -$1.82
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Alkermes, Inc..
CAPS Rating 4 out of 5
284 Outperform
14 Underperform
CAPS All Stars
73 Outperform
3 Underperform

How do you think Alkermes, Inc. will perform against the market?

You pick for Alkermes, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Richard F. Pops, CEO

100% Approve

Based on 24 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Alkermes, Inc..

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers